What Improvements Are Needed for Data Analytics in the Specialty Pharmaceutical Space?



 
Giannouris: Through the data standards being in place, then you actually derive or create standard analytics. So, if you have a standard data set to use and it’s broadly understood, then the analytics that can be derived and generated from that standard data set sort of becomes a standard as well.
 
That’s one way. It’s certainly not the only way. Different manufacturers have different data needs and a standard is not going to cover all of their needs.

Most Popular

Related Articles

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the impact orphan drugs have had on the specialty pharmaceutical industry.
Peter L. Salgo, MD; Steven L. D’Amato, RPh, BSPharm; Arturo Loaiza-Bonilla, MD, MSEd, FACP; Noa Biran, MD; and Carl T. Henningson, MD, remark on the role of specialty pharmacies in dispensing oral oncolytics.
Health care organizations show support for proposed Medicare Part D rules that require direct and indirect remuneration fees to be included at the point-of-sale.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.